Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Iván Sanz Muñoz"'
Autor:
Laura Sánchez de Prada, Iván Sanz Muñoz, Javier Castrodeza Sanz, Raúl Ortiz de Lejarazu Leonardo, José María Eiros Bouza
Publikováno v:
Vaccines, Vol 8, Iss 4, p 704 (2020)
Background: vaccination is the best approach to prevent influenza infections so far. Serological studies on the effect of different vaccine types are important to address vaccination campaigns and protect our population. In our study, we compared the
Externí odkaz:
https://doaj.org/article/6c9b59ab21da4b36983181dcddb5d9b5
Autor:
Vincent Pernin, Maria Meneghini, Alba Torija, Thomas Jouve, Arnaud Del Bello, Iván Sanz-Muñoz, Jose Maria Eiros, Laura Donadeu, Carol Polo, Francisco Morandeira, Sergio Navarro, Cristina Masuet, Alexandre Favà, Moglie LeQuintrec, Nassim Kamar, Elena Crespo, Oriol Bestard
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/43510219d4e94953bf8e4a54f682a640
Autor:
Laura Sánchez-de Prada, Ana María Martínez-García, Belén González-Fernández, Javier Gutiérrez-Ballesteros, Silvia Rojo-Rello, Sonsoles Garcinuño-Pérez, Alejandro Álvaro-Meca, Raúl Ortiz De Lejarazu, Iván Sanz-Muñoz, José M. Eiros
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract SARS-CoV-2 reinfections have been frequent, even among those vaccinated. The aim of this study is to know if hybrid immunity (infection + vaccination) is affected by the moment of vaccination and number of doses received. We conducted a retr
Externí odkaz:
https://doaj.org/article/fd9847bbe3db4c6d9871a834ffe1ad22
Autor:
Iván Sanz-Muñoz, Javier Sánchez-Martínez, Carla Rodríguez-Crespo, Irene Arroyo-Hernantes, Marta Domínguez-Gil, Silvia Rojo-Rello, Marta Hernández, José M Eiros
Publikováno v:
International Journal of Infectious Diseases, Vol 143, Iss , Pp 107034- (2024)
Objectives: The aim of this study was to analyze the viral load (VL) using cycle threshold (Ct) in patients infected with influenza A (H3N2). Methods: This prospective study was conducted during the 2022-2023 influenza season in sentinel, non-sentine
Externí odkaz:
https://doaj.org/article/28a27abc185e41829fd41c8953e2ca4c
Publikováno v:
Open Respiratory Archives, Vol 6, Iss 2, Pp 100320- (2024)
Nirsevimab therapy has the potential to revolutionize infant respiratory syncytial virus (RSV) prophylaxis. But other populations suffering RSV, such the elderly or those over 60, may also be protected by using this novel antibody in the infant group
Externí odkaz:
https://doaj.org/article/cc97af7bb87a4f768f2c2cd4293a44fd
Autor:
Iván Sanz-Muñoz, Conrado Lajara, Javier Sánchez-Martínez, Camino Prada-García, Silvia Rojo-Rello, Marta Domínguez-Gil, Virginia Fernández-Espinilla, Cristina Hernán-García, José M. Eiros-Bachiller, Asunción Caminero-Pérez, Yolanda Marcos-López, Luis Teso-Fernández, José Ignacio Echarren, Javier Castrodeza-Sanz, José M. Eiros
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 2 (2023)
The aim of this work is to describe the dynamics of influenza antibodies after vaccination in adults. We conducted a case-cohort serological study in the automobile manufacturing plants of the Renault España S.A. group in Valladolid and Palencia (Sp
Externí odkaz:
https://doaj.org/article/8b78b4bbea2b4c27831a204def7e08de
Autor:
Laura Sánchez-de Prada, Iván Sanz-Muñoz, Raúl Ortiz de Lejarazu, José María Eiros, Adolfo García-Sastre, Teresa Aydillo
Publikováno v:
Emerging Microbes and Infections, Vol 11, Iss 1, Pp 2670-2679 (2022)
Current influenza vaccines elicit humoral immune responses against the haemagglutinin (HA) protein of influenza viruses. Different antigenic sites have been identified in the HA head as the main target of haemagglutination inhibition (HAI) antibodies
Externí odkaz:
https://doaj.org/article/c48a61b6bf5c4bf6a3087b98a0a34d3b
Autor:
Iván Sanz-Muñoz, Laura Sánchez-dePrada, Javier Sánchez-Martínez, Silvia Rojo-Rello, Marta Domínguez-Gil, Cristina Hernán-García, Virginia Fernández-Espinilla, Raúl Ortiz de Lejarazu-Leonardo, Javier Castrodeza-Sanz, José María Eiros
Publikováno v:
Emerging Infectious Diseases, Vol 29, Iss 3, Pp 656-658 (2023)
Smallpox vaccination may confer cross-protection to mpox. We evaluated vaccinia virus antibodies in 162 persons ≥50 years of age in Spain; 68.5% had detectable antibodies. Highest coverage (78%) was among persons 71–80 years of age. Low antibody
Externí odkaz:
https://doaj.org/article/03fd1b8d6a8a40659950ed35be609f42
Autor:
Laura Sánchez-de Prada, Iván Sanz-Muñoz, Weina Sun, Peter Palese, Raúl Ortiz de Lejarazu, José María Eiros, Adolfo García-Sastre, Teresa Aydillo
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
ObjectiveAntibodies elicited by seasonal influenza vaccines mainly target the head of hemagglutinin (HA). However, antibodies against the stalk domain are cross-reactive and have been proven to play a role in reducing influenza disease severity. We i
Externí odkaz:
https://doaj.org/article/0f9000222055435b9a351171fdc3f802
Autor:
Joanna Waldock, Carol D. Weiss, Wei Wang, Min Z. Levine, Stacie N. Jefferson, Sammy Ho, Katja Hoschler, Brandon Z. Londt, Elisa Masat, Louise Carolan, Stephany Sánchez-Ovando, Annette Fox, Shinji Watanabe, Miki Akimoto, Aya Sato, Noriko Kishida, Amelia Buys, Lorens Maake, Cardia Fourie, Catherine Caillet, Sandrine Raynaud, Richard J. Webby, Jennifer DeBeauchamp, Rebecca J. Cox, Sarah L. Lartey, Claudia M. Trombetta, Serena Marchi, Emanuele Montomoli, Iván Sanz-Muñoz, José María Eiros, Javier Sánchez-Martínez, Danny Duijsings, Othmar G. Engelhardt
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionExternal Quality Assessment (EQA) schemes are designed to provide a snapshot of laboratory proficiency, identifying issues and providing feedback to improve laboratory performance and inter-laboratory agreement in testing. Currently there
Externí odkaz:
https://doaj.org/article/336faf037fe6487d9afa1b75516f9b2d